相关实验视频
Updated: Sep 11, 2025

03:36
Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
530
DNA/RNA结合蛋白KIN17通过解决R循环诱导的非正规STING激活来支持食道癌症的进展
Zichao Wei1, Ning Zhao1, Lu Kuang1
1State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China.
Signal transduction and targeted therapy
|August 14, 2025
概括
在食道状细胞癌 (ESCC) 中,DNA损伤反应 (DDR) 蛋白KIN通过解决R循环和抑制免疫力来促进癌症的进展. 抑制KIN激活了抗瘤免疫力,并提高了免疫治疗的有效性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 针对DNA损伤反应 (DDR) 可以增强抗瘤免疫力和患者的结果.
- 然而,某些癌症的补偿机制限制了DDR向治疗的有效性.
- 活性DDR蛋白在食道状细胞癌 (ESCC) 中的作用尚不清楚.
研究的目的:
- 研究DDR蛋白在ESCC进展中的功能.
- 确定DDR蛋白KIN对瘤免疫微环境的影响.
- 探索KIN在R循环解析中的作用及其在ESCC中的治疗潜力.
主要方法:
- 在ESCC组织中分析DDR基因表达.
- 在ESCC细胞中KIN的耗尽和扩散和DNA损伤的评估.
- 研究了KIN与DHX9和R循环分辨率的相互作用.
- 评估KIN枯竭后的STING通路激活和免疫反应.
- 在小鼠模型中评估了对免疫微环境和免疫治疗的KIN枯竭效应.
主要成果:
- 增加DDR基因表达与ESCC进展和抑制的免疫微环境相关.
- 在ESCC中丰富的KIN促进了DNA损伤的修复和亡的规避.
- 基因枯竭抑制ESCC细胞增殖,增加DNA损伤,并通过NFκB信号激活STING通路.
- 基因作为R循环结合蛋白,招募DHX9来解决DNA损伤相关的R循环.
- 在小鼠模型中,KIN的耗尽改善了免疫微环境,并提高了免疫治疗的疗效.
结论:
- 基因是一种新的R环结合蛋白,通过解决R环和抑制先天免疫力来促进ESCC的进展.
- 向KIN可以通过重新激活抗瘤免疫反应来克服对DDR向疗法的耐药性.
- 抑制KIN是一种潜在的治疗策略,可以增强ESCC的免疫疗法.
相关概念视频
Restarting Stalled Replication Forks
5.9K
DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
5.9K
lncRNA - Long Non-coding RNAs
8.9K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.9K
DNA Damage can Stall the Cell Cycle
9.3K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.3K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Rous Sarcoma Virus (RSV) and Cancer
5.4K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.4K

